Flohale Respules contain fluticasone propionate. However, the exact 2 mg strength and its presentation must be verified against the original packaging. Do not assume that 2 mg refers to the total quantity per respule, the concentration per mL, or the prescribed dose.
Flohale is an inhaled corticosteroid used to control airway inflammation. It is not a rescue medicine for sudden asthma attacks. Higher corticosteroid exposure can increase the risk of systemic adverse effects, including adrenal suppression.
What Are Flohale 2 mg Respules?
Flohale 2 mg Respules are a nebulised respiratory medicine containing fluticasone propionate, a corticosteroid that helps reduce inflammation in the airways.
Fluticasone propionate belongs to the inhaled glucocorticoid group of medicines.
Asthma is a chronic inflammatory condition that causes the airways to become swollen, sensitive, and prone to narrowing.
These changes may produce symptoms such as wheezing, coughing, shortness of breath, and chest tightness.
Fluticasone works by suppressing inflammatory pathways involved in asthma.
It helps reduce swelling of the airway lining and may decrease the frequency of asthma symptoms when used consistently.
Respules contain a liquid preparation designed for administration through a compatible nebuliser.
The nebuliser converts the medicine into an aerosol that can be inhaled into the respiratory tract.
Nebulised therapy may be useful for selected patients who have difficulty using other inhalation devices or require a specific prescribed treatment approach.
Flohale is intended for maintenance treatment rather than immediate symptom relief.
Common Reasons for Prescribing Flohale Respules
- Maintenance treatment of bronchial asthma
- Persistent asthma management
- Reduction of chronic airway inflammation
- Control of recurrent asthma-related wheezing
- Management of asthma-related coughing
- Prevention of asthma exacerbations
- Reduction of nighttime asthma symptoms
- Long-term respiratory maintenance therapy
- Nebulised corticosteroid treatment
- Specialist-directed management of difficult-to-control asthma
Important: A 2 mg fluticasone presentation may represent substantial corticosteroid exposure. The correct dose, indication, and treatment duration must be established by a respiratory specialist.
How Do Flohale 2 mg Respules Work?
1. Deliver Fluticasone to the Airways
A compatible nebuliser converts the prescribed suspension into an inhalable aerosol.
2. Activate Glucocorticoid Receptors
Fluticasone binds to glucocorticoid receptors within cells.
3. Suppress Inflammatory Gene Expression
The medicine modifies the activity of genes involved in inflammatory signaling.
4. Reduce Airway Inflammation
Fluticasone decreases inflammatory activity in the bronchial lining.
5. Reduce Airway Swelling
By controlling inflammation, it helps reduce swelling within the respiratory airways.
6. Decrease Airway Hyperresponsiveness
Regular corticosteroid therapy may reduce excessive airway sensitivity to asthma triggers.
7. Suppress Inflammatory Cell Activity
Fluticasone reduces the activity of inflammatory cells involved in asthma.
8. Improve Long-Term Symptom Control
Regular treatment may reduce the frequency of coughing, wheezing, and chest tightness.
9. Reduce Exacerbation Risk
Effective inhaled corticosteroid treatment can reduce the likelihood of asthma flare-ups.
10. Support Respiratory Stability
Consistent treatment helps maintain better long-term asthma control in appropriately selected patients.
Important: Fluticasone does not directly relax airway smooth muscle. It cannot replace a fast-acting bronchodilator during an acute asthma attack.
Uses of Flohale 2 mg Respules
1. Bronchial Asthma
Flohale may be prescribed for maintenance treatment of bronchial asthma.
2. Persistent Asthma
It helps control chronic inflammation associated with persistent asthma.
3. Difficult-to-Control Asthma
Higher corticosteroid doses may be considered in selected patients whose asthma remains inadequately controlled, following specialist assessment.
4. Asthma Exacerbation Prevention
Regular anti-inflammatory therapy may reduce the risk of asthma flare-ups.
5. Asthma-Related Wheezing
It may help reduce recurrent wheezing caused by airway inflammation.
6. Asthma-Related Cough
Fluticasone may help manage coughing associated with persistent asthma.
7. Nighttime Asthma Symptoms
Effective controller therapy may reduce nighttime coughing and breathing difficulties.
8. Chronic Airway Inflammation
Fluticasone suppresses inflammatory processes within the respiratory tract.
9. Airway Hyperresponsiveness
Regular treatment may reduce excessive airway sensitivity to environmental triggers.
10. Long-Term Asthma Management
Flohale may be included in an individualized respiratory treatment plan.
11. Nebulised Corticosteroid Therapy
The respule formulation provides a method of delivering inhaled corticosteroid medication.
12. Specialist-Directed Respiratory Treatment
A respiratory specialist may prescribe nebulised fluticasone when clinically appropriate.
Important: Do not advertise Flohale 2 mg Respules as an approved treatment for COPD, pneumonia, bronchiolitis, or other respiratory conditions unless supported by the exact product’s approved prescribing information.
Flohale 2 mg Respules Dosage and Administration
The correct dose depends on the exact concentration, age, asthma severity, previous corticosteroid exposure, clinical response, and the prescribing specialist’s assessment.
General Dosage Information
| Dosage Information | Details |
|---|---|
| Active Ingredient | Fluticasone Propionate |
| Listed Strength | 2 mg |
| Equivalent Amount | 2000 mcg |
| Dosage Form | Nebuliser Suspension |
| Administration Route | Oral Inhalation by Nebuliser |
| Dose per Session | As prescribed |
| Frequency | Determined by the prescriber |
| Treatment Duration | Based on clinical assessment |
| Nebuliser Type | Compatible device specified by the manufacturer |
| Emergency Asthma Relief | Not suitable |
| Medical Supervision | Required |
Important: The 2 mg strength must not be interpreted as an instruction to administer an entire respule. Confirm the actual concentration, container volume, and prescribed dose.
How to Use Flohale 2 mg Respules
- Wash your hands before handling the medicine.
- Confirm the product name and strength.
- Check the expiry date.
- Inspect the respule for damage.
- Confirm that the nebuliser is compatible with the prescribed suspension.
- Prepare the nebuliser according to the manufacturer’s instructions.
- Gently resuspend the medicine if instructed on the label.
- Open the respule immediately before use.
- Place the prescribed quantity into the nebuliser chamber.
- Do not mix with other medicines unless compatibility is confirmed.
- Attach the appropriate mouthpiece or face mask.
- Sit upright during treatment.
- Switch on the nebuliser.
- Breathe normally through the mouthpiece or mask.
- Continue until the prescribed nebulisation is complete.
- Switch off the device.
- Discard remaining medicine according to the manufacturer’s instructions.
- Rinse your mouth with water and spit it out.
- Wash the face after treatment if a face mask was used.
- Clean and dry the nebuliser components as instructed.
- Store unopened respules according to the product label.
Can Flohale 2 mg Respules Be Used Every Day?
They may be prescribed for regular maintenance therapy.
However, the dose and frequency must be confirmed because higher corticosteroid exposure increases the risk of systemic side effects.
Can Flohale 2 mg Be Used During an Asthma Attack?
No.
Flohale is not a fast-acting bronchodilator and should not be used as the sole treatment for sudden breathing difficulties.
Can Flohale Be Mixed With Other Nebuliser Medicines?
Only when compatibility has been confirmed by the manufacturer or healthcare professional.
Do not automatically mix Flohale with salbutamol, levosalbutamol, ipratropium, or other nebulised medicines.
What If a Dose Is Missed?
Use the missed dose when remembered unless it is nearly time for the next scheduled dose.
Do not double the dose.
Can Flohale Be Stopped Suddenly?
Do not independently stop regular asthma controller treatment.
Abrupt discontinuation may worsen asthma control, and patients receiving high corticosteroid exposure may require additional medical supervision.
How Long Do Flohale 2 mg Respules Take to Work?
Fluticasone begins acting on inflammatory pathways after inhalation.
However, it does not provide immediate relief from bronchospasm.
Some improvement may occur within several days.
More consistent asthma control may require one to several weeks.
Response depends on asthma severity, correct nebuliser use, adherence, and individual patient factors.
Important: Severe breathing difficulties require an appropriate rescue treatment plan and urgent medical attention when indicated.
Common Side Effects
Possible side effects include:
- Oral thrush
- Hoarseness
- Throat irritation
- Sore throat
- Coughing after nebulisation
- Dry mouth
- Unpleasant taste
- Voice changes
- Headache
- Mild respiratory irritation
- Facial skin irritation when using a mask
The likelihood of systemic adverse effects may increase with higher doses or prolonged treatment.
Potentially Harmful Effects & Serious Health Risks
1. Oral Candidiasis
Fluticasone may increase the risk of fungal infection in the mouth and throat.
2. Hoarseness
Inhaled corticosteroids may cause voice changes.
3. Paradoxical Bronchospasm
Rarely, inhalation may cause sudden worsening of wheezing or breathing difficulty.
4. Adrenal Suppression
High-dose or prolonged corticosteroid exposure may suppress normal adrenal hormone production.
5. Adrenal Crisis
Patients with significant adrenal suppression may be at risk of adrenal crisis during severe illness or physiological stress.
6. Cushingoid Effects
Excessive systemic corticosteroid exposure may cause weight changes, facial rounding, and other Cushingoid features.
7. Growth Suppression in Children
Long-term inhaled corticosteroid treatment may reduce growth velocity.
8. Reduced Bone Mineral Density
Prolonged corticosteroid exposure may affect bone health.
9. Osteoporosis
Patients with additional risk factors may be more susceptible to bone loss.
10. Cataracts
Long-term corticosteroid exposure may increase cataract risk.
11. Glaucoma
Inhaled corticosteroids may contribute to increased intraocular pressure.
12. Increased Susceptibility to Infections
Corticosteroid therapy may influence immune responses.
13. Hyperglycemia
Systemic corticosteroid exposure may affect blood glucose regulation.
14. Severe Allergic Reactions
Rare hypersensitivity reactions may occur.
15. Drug Interaction-Related Toxicity
Strong CYP3A4 inhibitors may substantially increase systemic fluticasone exposure.
16. Respiratory Infection Complications
Patients with active respiratory infections may require additional assessment.
17. Inadequate Nebuliser Delivery
Incorrect device use may reduce the amount of medicine reaching the lungs.
18. Poor Asthma Control
Incorrect dosing or inconsistent treatment may increase the risk of exacerbations.
Emergency warning: Seek immediate medical attention for severe breathing difficulty, sudden worsening of wheezing after nebulisation, facial or throat swelling, or symptoms suggesting a serious allergic reaction.
Contraindications & Safety Precautions
1. Hypersensitivity to Fluticasone
Do not use the medicine if allergic to fluticasone propionate or any formulation ingredient.
2. Acute Asthma Attacks
Flohale is not suitable as the primary treatment for acute asthma symptoms.
3. Status Asthmaticus
Life-threatening asthma requires emergency medical treatment.
4. High-Dose Corticosteroid Exposure
Higher doses may increase the risk of systemic adverse effects.
5. Adrenal Suppression
Patients with existing adrenal disorders or prolonged corticosteroid exposure may require additional monitoring.
6. Tuberculosis
Patients with active or previous tuberculosis should inform their healthcare professional.
7. Respiratory Infections
Active respiratory infections may require additional medical assessment.
8. Fungal Infections
Inhaled corticosteroids may increase the risk of oral candidiasis.
9. Liver Disease
Significant liver impairment may increase systemic corticosteroid exposure.
10. Osteoporosis
Patients with reduced bone density may require monitoring during prolonged treatment.
11. Glaucoma and Cataracts
Patients with eye disorders should report visual changes.
12. Diabetes
High systemic corticosteroid exposure may affect blood glucose control.
13. Pregnancy
Maintaining adequate asthma control during pregnancy is important.
Fluticasone may be used when clinically appropriate following medical assessment.
14. Breastfeeding
Inhaled fluticasone is generally considered compatible with breastfeeding at recommended doses, although higher-dose treatment warrants individualized assessment.
15. Children
Pediatric use depends on the approved age range, formulation, and prescribed dose.
Growth should be monitored during prolonged treatment.
16. Older Adults
Older patients may require additional monitoring for bone health, eye complications, and systemic corticosteroid effects.
17. Drug Interactions
Potentially important interactions include:
- Ritonavir: May substantially increase systemic fluticasone exposure.
- Cobicistat-Containing Medicines: May increase the risk of systemic corticosteroid effects.
- Ketoconazole: May increase fluticasone concentrations.
- Itraconazole: May increase systemic corticosteroid exposure.
- Other Strong CYP3A4 Inhibitors: May increase the risk of adrenal suppression.
- Other Corticosteroids: May increase cumulative corticosteroid exposure.
18. Nebuliser Compatibility
Use only a compatible nebuliser specified in the product instructions.
19. Nebuliser Hygiene
Poorly maintained equipment may increase contamination risk.
20. Medical Monitoring
Healthcare professionals may monitor:
- Asthma symptom frequency
- Nighttime symptoms
- Rescue inhaler use
- Lung function
- Asthma exacerbations
- Nebuliser technique
- Oral thrush
- Hoarseness
- Growth in children
- Bone mineral density when indicated
- Eye symptoms
- Blood glucose when indicated
- Adrenal function when clinically appropriate
- Signs of systemic corticosteroid exposure
- Treatment adherence
- Need for dose adjustment
Advantages
- Inhaled corticosteroid therapy.
- Direct delivery to the respiratory airways.
- Helps control chronic airway inflammation.
- Supports maintenance asthma treatment.
- May reduce recurrent asthma symptoms.
- May reduce nighttime asthma symptoms.
- May prevent asthma exacerbations.
- May improve long-term asthma control.
- May reduce reliance on rescue bronchodilators.
- Nebuliser-based administration.
- Established anti-inflammatory mechanism.
- May be appropriate for selected patients requiring nebulised therapy.
- Supports individualized respiratory management.
Disadvantages / Limitations
- Does not provide immediate asthma relief.
- Requires compatible nebuliser equipment.
- Requires correct administration technique.
- May cause oral thrush.
- May cause hoarseness.
- May cause throat irritation.
- May cause coughing after inhalation.
- May cause paradoxical bronchospasm.
- Higher doses may increase adrenal suppression risk.
- May cause systemic corticosteroid effects.
- Long-term use may affect growth velocity in children.
- May reduce bone mineral density.
- May increase cataract risk.
- May increase glaucoma risk.
- May interact with strong CYP3A4 inhibitors.
- Requires regular treatment adherence.
- May require additional monitoring at higher doses.
- Does not permanently cure asthma.
- Cannot replace emergency rescue treatment.
- Exact 2 mg formulation must be verified before use or publication.
Important Notes
Generic Name: Fluticasone Propionate.
Product Name: Flohale 2 mg Respules.
Listed Strength: 2 mg (2000 mcg), subject to formulation verification.
Drug Class: Inhaled Corticosteroid.
Therapeutic Category: Respiratory Medicine / Asthma Controller.
Primary Use: Maintenance treatment of bronchial asthma.
Mechanism: Suppression of inflammatory activity in the respiratory airways.
Administration Route: Inhalation by Nebuliser.
Dosage Form: Nebuliser Suspension.
Brand: Flohale.
Brand / Marketer: Cipla, subject to product verification.
Major Warning: Not suitable for immediate relief during acute asthma attacks.
Common Side Effects: Oral thrush, hoarseness, and throat irritation.
Serious Risks: Adrenal suppression, paradoxical bronchospasm, and systemic corticosteroid effects.
Pregnancy: Use according to medical assessment.
Breastfeeding: Requires individualized assessment at higher doses.
Pediatric Use: Follow formulation-specific age restrictions.
Monitoring: Asthma control, adrenal function when indicated, growth in children, and other corticosteroid-related adverse effects.
Prescription Status: Prescription Medicine.
Storage: Follow manufacturer instructions.
Frequently Asked Questions
1. What are Flohale 2 mg Respules used for?
Flohale Respules may be prescribed for maintenance treatment of bronchial asthma when nebulised fluticasone is clinically appropriate.
2. What is the generic name of Flohale Respules?
The generic name is fluticasone propionate.
3. Is Flohale a steroid medicine?
Yes. Fluticasone propionate is an inhaled corticosteroid.
4. How do Flohale Respules work?
They reduce inflammatory activity in the airways, helping control asthma symptoms over time.
5. Can Flohale provide immediate asthma relief?
No. Flohale is a controller medicine and does not provide rapid bronchodilation.
6. Can Flohale help reduce wheezing?
Yes. Regular treatment may reduce wheezing associated with asthma-related inflammation.
7. Can Flohale help with asthma-related coughing?
Yes. It may help control coughing caused by persistent airway inflammation.
8. Can Flohale 2 mg Respules be used every day?
They may be prescribed for regular treatment, but the exact dose and frequency require specialist confirmation.
9. Can Flohale prevent asthma attacks?
Regular inhaled corticosteroid therapy may reduce asthma exacerbation risk but cannot eliminate it completely.
10. Can Flohale cause oral thrush?
Yes. Oral candidiasis is a recognized side effect.



































































Reviews
There are no reviews yet.